Ardent Health Partners Affirms FY2025 GAAP EPS Guidance of $1.73-$2.01 vs $1.90 Est; Affirms FY2025 Sales Guidance of $6.20B-$6.45B vs $6.33B EstARDTMay 6, 2025Read more →
Ardent Health Partners Q1 EPS $0.29 Beats $0.20 Estimate, Sales $1.50B InlineARDTMay 6, 2025Read more →
Guggenheim Initiates Coverage On Ardent Health Partners with Buy Rating, Announces Price Target of $16ARDTApril 9, 2025Read more →
Mizuho Maintains Outperform on Ardent Health Partners, Lowers Price Target to $18ARDTApril 9, 2025Read more →
Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $22 Price TargetARDTApril 1, 2025Read more →
Deep Dive Into Ardent Health Partners Stock: Analyst Perspectives (5 Ratings)ARDTMarch 26, 2025Read more →
Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $22 Price TargetARDTMarch 26, 2025Read more →
RBC Capital Maintains Outperform on Ardent Health Partners, Lowers Price Target to $21ARDTMarch 4, 2025Read more →
A Glimpse Into The Expert Outlook On Ardent Health Partners Through 4 AnalystsARDTFebruary 27, 2025Read more →
Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $22 Price TargetARDTFebruary 27, 2025Read more →
Ardent Health Partners Sees FY25 EPS $1.73-$2.01 Vs $1.94 Est.; Revenue $6.20B-$6.45B Vs $6.297B Est.ARDTFebruary 26, 2025Read more →
Ardent Health Partners Q4 2024 GAAP EPS $0.81 Beats $0.44 Estimate, Sales $1.610B Beat $1.484B EstimateARDTFebruary 26, 2025Read more →
RBC Capital Reiterates Outperform on Ardent Health Partners, Maintains $23 Price TargetARDTNovember 14, 2024Read more →
Ardent Health Raises FY24 Revenue To $5.8B-$5.875B From $5.75B-$5.9B; Updates Diluted EPS To $1.18-$1.32 From $1.23-$1.37ARDTNovember 6, 2024Read more →
Ardent Health Partners Q3 2024 GAAP EPS $0.19 Misses $0.30 Estimate, Sales $1.45B InlineARDTNovember 6, 2024Read more →
This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday (CORRECTED)ARDTNovember 6, 2024Read more →